Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.56 |
| ▸ | SQLE | Q14534 | 6/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21790 | 1.00 | KMT2A (0.64) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL2768657 | 1.00 | KMT2A (0.64) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL25185 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL158029 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL4954725 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL10670740 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL11406888 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL16892794 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL11406885 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL73978 | 0.95 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037433-B2 | (Co)polymers of hydrophobic monomers and methods of making and use thereof | BASF SE (DE) | 2024-07-16 | — | — | US | claimed |
| WO-2023083884-A1 | STABILIZERS BASED ON SYRINGIC ACID, VANILLIC ACID, ISOVANILLIC ACID OR 5-HYDROXYVERATRIC ACID, PLASTIC COMPOSITION, METHOD FOR STABILIZING A PLASTIC COMPOSITION AND STABILIZER COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-05-19 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| US-20220387376-A1 | Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents | NATURAL EXTRACTION SYS LLC (US) | 2022-12-08 | — | — | US | claimed |
| WO-2022072663-A1 | STABILIZED ALKYL NITRITE COMPOSITIONS | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) | 2022-04-07 | — | — | WO | claimed |
| US-20210403408-A1 | CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION | INMED PHARMACEUTICALS INC. (CA) | 2021-12-30 | — | — | US | claimed |
| EP-3873451-A1 | CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION | BayMedica, Inc. (US) | 2021-09-08 | — | — | EP | claimed |
| US-11091424-B2 | Preparation of acetate compounds via a ketene compound | BASF SE (DE) | 2021-08-17 | — | — | US | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-5919752-A | ORTHOESTERS, KETALS, ACETALS, ORTHOCARBONATES WHICH RELEASE TWO OR MORE FRAGRANCE RAW MATERIALS UPON HYDROLYSIS. | PROCTER & GAMBLE (US) | 1999-07-06 | — | — | US | claimed |
| WO-1999016740-A1 | PROCESS FOR PREPARING BETA-KETOESTER FRAGRANCE PRO-ACCORDS FROM 1,3-DIOXAN-4,6-DIONES | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-08 | — | — | WO | claimed |
| WO-1999004789-A1 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA, INC. (US) | 1999-02-04 | — | — | WO | claimed |
| WO-1998047477-A1 | FRAGRANCE PRO-ACCORDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| US-5726345-A | Process for perfuming textiles | FIRMENICH S.A. (CH) | 1998-03-10 | — | — | US | claimed |
| US-5059627-A | For mammals suffering from degenerative nervous system disorders | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-10-22 | — | — | US | claimed |
| US-4822908-A | Substituted acrylates and fungicides containing same | BASF AKTIENGESELLSCHAFT (DE) | 1989-04-18 | — | — | US | claimed |
| EP-0259752-A2 | Saccharide phosphates, their esters and method for their preparation | BAYER AG (DE) | 1988-03-16 | — | — | EP | claimed |
| EP-0127536-B1 | PROCESS FOR THE PREPARATION OF ALPHA-DELTA-DIETHYLENIC CARBONYL COMPOUNDS | RHONE-POULENC SANTE (FR) | 1987-01-21 | — | — | EP | claimed |
| US-4556742-A | Process for the preparation of α,δ-diethylenic carbonyl compounds | RHONE-POULENC SANTE (FR) | 1985-12-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387376-A1 | Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents | CNR2, CNR1, PHOSPHO1 | KMT2A 4062/4885ALOX15 1281/4885MEN1 2631/4885 |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | KMT2A 4742/4885ALOX15 359/4885MEN1 1711/4885 |
| US-11091424-B2 | Preparation of acetate compounds via a ketene compound | AKR1C2, KAT8, KAT5 | KMT2A 172/4885ALOX15 1608/4885MEN1 841/4885 |
| US-20210403408-A1 | CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION | CNR1, CNR2, ERG28 | KMT2A 1038/4885ALOX15 1832/4885MEN1 2665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.